DOI: 10.1128/mSphere.00282-19
Article Information
PubMed
Published By
History
- Published online June 19, 2019.
Copyright & Usage
Copyright © 2019 Tournier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Patricia A. Bradford, Editor, Antimicrobial Development Specialists, LLC
Author Information
- aInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France
- bInstitut Pasteur, Viral Genomics and Vaccination Unit, CNRS UMR-3569, Paris, France
- cNational Reference Center for Anthrax (CNR-LE Charbon), Brétigny-sur-Orge, France
- dEcole du Val-de-Grâce, Paris, France
- eInstitut Pasteur, Yersinia Unit, Paris, France
- Address correspondence to Jean-Nicolas Tournier, jntournier.irba{at}gmail.com.
Citation Tournier J-N, Rougeaux C, Biot FV, Goossens PL. 2019. Questionable efficacy of therapeutic antibodies in the treatment of anthrax. mSphere 4:e00282-19. https://doi.org/10.1128/mSphere.00282-19.
